Records containing: Oligodendroglioma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-10-15Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes
-
CLINICAL_TRIALS study record update · 2024-08-09A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
-
CLINICAL_TRIALS study record update · 2024-06-14Pilot Randomized Neo-adjuvant Evaluation of Agonist Anti-CD27 Monoclonal Antibody Varlilumab on Immunologic Activities of IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
-
CLINICAL_TRIALS study record update · 2024-02-08Role of Ga-68 Prostate Specific Membrane Antigen PET/CT in Detection of Recurrence in Patients With Gliomas
-
CLINICAL_TRIALS study record update · 2023-12-14Defining Personal and Communal Aspects of Social Determinants of Health in Glioblastoma Population
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-11-22Artificial Intelligence Research of Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning
-
CLINICAL_TRIALS study record update · 2022-10-07A Phase Ib/2 Open-label Study Investigating the Tolerability, Safety, Pharmacokinetic Properties and Efficacy of Oral OKN-007 in Participants With Recurrent High-grade Glioma
-
CLINICAL_TRIALS study record update · 2022-09-27Phase 2 Study to Evaluate the Clinical Efficacy and Safety of Sintilimab Plus Low-dose Bevacizumab in Patients With Oligodendroglioma of Different Relapse Stages
-
CLINICAL_TRIALS study record update · 2022-05-16G-FORCE-1: An Open-Label Phase 1 Two Part Dose Escalation Trial of RRx-001 Concurrent With Radiation and Temozolomide and RRx-001 + Temozolomide Post-RT In Newly Diagnosed Glioblastoma and Anaplastic Gliomas With Intact 1p/19q Chromosomes
-
CLINICAL_TRIALS study record update · 2021-10-29Determining the Competence of the Immune System Over the First Year of Therapy in Patients With Glioma: A Battery of Quantitative, Qualitative and Functional Measures of Immune Readiness
-
CLINICAL_TRIALS study record update · 2021-07-21Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models: a Case-control Study
-
CLINICAL_TRIALS study record update · 2021-04-13Proteomic Characterization of Aggressive Oligodendrogliomas
-
CLINICAL_TRIALS study record update · 2020-12-10Pilot Trial of NovoTTF -200A (TTFields) in Patients With Newly Diagnosed High Risk Oligodendrogliomas
-
CLINICAL_TRIALS study record update · 2020-12-04The PIONEER Initiative: Precision Insights On N-of-1 Effectiveness Research. Tissue Ownership by the Individual With the Return of Actionable Information to the Individual Patient and Physician (Precision Oncology)
-
CLINICAL_TRIALS study record update · 2020-09-02The Neural Basis of Language: A New Lighting. Study of Semantic Processing in MRI Mutimodale and Direct Electrical Stimulation
-
CLINICAL_TRIALS study record update · 2020-07-24A Phase II Clinical Trial Evaluating Combination Therapy Using DCVax-L (Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen) and Nivolumab (an Anti-PD-1 Antibody) for Subjects With Recurrent Glioblastoma Multiforme
-
CLINICAL_TRIALS study record update · 2020-05-28Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma
-
CLINICAL_TRIALS study record update · 2020-03-24A Phase II/III Randomized, Open-Label Study of Toca 511, A Retroviral Replicating Vector, Combined With Toca FC With Temozolomide and Radiation Followed by Adjuvant Temozolomide and Toca FC Compared to Temozolomide and Radiation Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
-
CLINICAL_TRIALS study record update · 2020-01-27A PHASE 1 DOSE ESCALATION STUDY EVALUATING THE SAFETY AND TOLERABILITY OF PF-06840003 IN PATIENTS WITH MALIGNANT GLIOMAS
-
CLINICAL_TRIALS study record update · 2019-12-12Evaluation of the Natural History of Patients With Tumors of the Central Nervous System
-
CLINICAL_TRIALS study record update · 2019-12-09A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas: The Glioma Molecular Diagnostic Initiative
-
CLINICAL_TRIALS study record update · 2019-11-07Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute (NCI) Clinical Research Protocols
-
CLINICAL_TRIALS study record update · 2019-02-21A Prospective Cohort to Study the Effect of Postoperative Upfront Temozolomide Chemotherapy on IDH Mutational Low Grade Gliomas in Eloquent Areas
-
CLINICAL_TRIALS study record update · 2018-07-20A Molecular Biology and Phase II Study of Imetelstat (GRN163L) in Children With Recurrent High-Grade Glioma, Ependymoma and Diffuse Intrinsic Pontine Glioma
-
CLINICAL_TRIALS study record update · 2017-02-27Phase II Double-Blinded Placebo-Controlled Study of Bevacizumab With or Without AMG 386 in Patients With Recurrent Glioblastoma or Gliosarcoma